Minerva Surgical, Inc. (UTRS) Q2 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Minerva Surgical second quarter 2022 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. To ask a question, simply press star 1-1 on your telephone keypad. I would now like to hand the conference over to your speaker today, Carolyn Corner with Investor Relations. Please go ahead. Thank you, Operator. Welcome to Minerva's second quarter 2022 earnings call. Joining me on today's call are Dave Clapper, President and Chief Executive Officer, and Joel Young, Chief Financial Officer. This call will provide forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Minerva Surgical operates, trends and expectations for Minerva's products and technology, trends and demands for Minerva's products, Minerva's expected financial performance, expenses, and position in the market, and outlook for fiscal year 2022, and the impact of COVID-19 and its variance on Minerva operations and Minerva's customers' operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Minerva's most recent filings with SEC, particularly the risk factors described in Minerva's quarterly report on Form 10-Q for the q...